Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...
SAHPRA cautions the public to not purchase and/or consume such products as their safety, efficacy, and quality have not been ...
which is one of the registered products containing GLP-1 agonists from Novo Nordisk. According to the watchdog, Ozempic in ...
The SA Health Products Regulatory Authority has expressed concern at the increasing presence of counterfeit products such as ...
Sahpra warns against counterfeit GLP-1 products like Ozempic, citing health risks. Only registered products should be used; ...
The ‘Ozempic drug,’ semaglutide, has been found to reduce moderately severe pain caused by knee osteoarthritis and improve ...
Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...
The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versi ...
Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...
Medications like Ozempic and Wegovy, which are used to treat type 2 diabetes and boost weight loss, may also help reduce knee osteoarthritis-related pain in people with obesity, a trial finds.